Ruby Umesh Pawankar

Last updated

Ruby Umesh Pawankar Ruby Umesh Pawankar (cropped).jpg
Ruby Umesh Pawankar

Ruby Pawankar has been president of the World Allergy Organization (WAO), 2012 and 2013. She is the first Indian and first woman president of WAO, which was established in 1951. Currently she is past president, WAO, president of the Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI) and council member of Collegium Internationale Allergolicum (CIA). She is professor of allergy, department of pediatrics at Nippon Medical School in Tokyo, Japan, and guest professor at Showa University School of Medicine, Tokyo, Japan, Kyung Hee University School of Medicine, Seoul, Korea and St. John's Medical College, Bengaluru, India. She is a recipient of Pravasi Bharatiya Samman 2010 for excellence in medicine, from the president of India. [1]

Contents

Biography

She was born in Kolkata,West Bengal,[[India], to T.K. Mathew, Kunnukuzhiyil, Puthuppally in Kottayam, Kerala, India. She studied in Loreto, Kolkata and did her undergraduate medical education from the Armed Forces Medical College, Pune, India, and her post graduation from B.J. Medical College, Pune, Maharashtra, India. She then underwent training in allergy and clinical immunology from Nippon Medical School and Juntendo University School of Medicine, Tokyo Japan. She received her doctorate in allergy and clinical immunology from Nippon Medical School.

Career

Ruby Pawankar serves on numerous committees and boards of many academic organizations and grant reviews, is a Member/Fellow of several academic organizations including the Collegium International Allergolicum, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy and Immunology the European Academy of Allergy and Clinical Immunology and the Japanese Society of Allergology etc. She is currently also the President of the Indian Academy of Allergy and Advisor to the International Committee of the Japanese Society of Allergology. She is a member of the ELN Network, Inflame, the World Universities Network, GARD, Board member of Interasma.

Besides her clinical and teaching assignments in allergy, her research has focused on the cellular and molecular mechanisms of allergy, impact of environmental pollutants, and novel therapies for allergies. Among her key contributions is the role of gamma delta T cells in allergy and that of mast cells with increased Fcepsilon receptor expression as a major source of the obligatory pro- allergic Th2 cytokines capable of driving local allergen-specific IgE synthesis. This has formed the basis of the successful therapies targeting these cytokines with biological therapeutics today. Her research and educational activities have been strongly translational as it applies to clinical science. She has worked on the role of environmental factors including particulate matter and mite allergens on respiratory allergies and the role of epithelial cells in regulating immune inflammation in allergic airway disease This has resulted in 498 publications with a h-index of 64. She is an Editor of several peer-reviewed journals and books including ‘Allergy Frontiers’, the WAO White Book on Allergy, Update on Respiratory Disorders.

Ruby Pawankar has presided as President/Congress Chair several international congresses including the International Symposium in Allergy and Asthma (ISBAAR) in Tokyo, Japan in 2001, the 10th Trans Pacific Allergy Congress in 2004, in Mumbai, India, the 9th Asian Rhinology Symposium, the Middle East Allergy Asthma Immunology Congress in 2009, 2011, 2015, the WAO International Scientific Conference (WISC) 2012, in Hyderabad, India and the World Allergy Asthma Congress 2013 (WAAC 2013), Milan, Italy. [2] [3]

Published articles include "Asthma insights and reality in the United Arab Emirates" through NCBI. [4]

Recognition

Dr. Pawankar has focused on the furtherance of India-Japan medical collaboration for a number of years. She is recognised in Japan and worldwide for her outstanding contributions to science in the field of allergy asthma and clinical immunology. Other academic awards include the International Distinguished Fellow Award of ACAAI, the Life Time Achievement Award in Allergy, DN Shivpuri Oration, the SK Malik Oration, Global Accelator Award and the World Achievement Award.

YearCountry of ResidenceAward NameGiven byField of Merit
2010Flag of Japan.svg  Japan Pravasi Bharatiya Samman President of India Medicine

Related Research Articles

<span class="mw-page-title-main">Allergic rhinitis</span> Nasal inflammation due to allergens in the air

Allergic rhinitis, of which the seasonal type is called hay fever, is a type of inflammation in the nose that occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes. The fluid from the nose is usually clear. Symptom onset is often within minutes following allergen exposure, and can affect sleep and the ability to work or study. Some people may develop symptoms only during specific times of the year, often as a result of pollen exposure. Many people with allergic rhinitis also have asthma, allergic conjunctivitis, or atopic dermatitis.

<span class="mw-page-title-main">Food allergy</span> Hypersensitivity reaction to a food

A food allergy is an abnormal immune response to food. The symptoms of the allergic reaction may range from mild to severe. They may include itchiness, swelling of the tongue, vomiting, diarrhea, hives, trouble breathing, or low blood pressure. This typically occurs within minutes to several hours of exposure. When the symptoms are severe, it is known as anaphylaxis. A food intolerance and food poisoning are separate conditions, not due to an immune response.

<span class="mw-page-title-main">Allergen immunotherapy</span> Medical treatment for environmental allergies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies, such as insect bites, and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.

Nambudripad's Allergy Elimination Techniques (NAET) is a form of alternative medicine which proponents claim can treat allergies and related disorders. The techniques were devised by Devi Nambudripad, a California-based chiropractor and acupuncturist, in 1983, drawing on a combination of ideas from applied kinesiology, acupuncture, acupressure, nutritional management, and chiropractic methods.

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 68% of its revenue coming from sales in Europe.

<span class="mw-page-title-main">Kimishige Ishizaka</span> Japanese immunologist (1925–2018)

Kimishige "Kimi" Ishizaka was a Japanese immunologist who, with his wife Teruko Ishizaka, discovered the antibody class Immunoglobulin E (IgE) in 1966–1967. Their work was regarded as a major breakthrough in the understanding of allergy. He was awarded the 1973 Gairdner Foundation International Award and the 2000 Japan Prize for his work in immunology.

<span class="mw-page-title-main">World Allergy Organization</span>

The World Allergy Organization (WAO) is an international umbrella organization of 108 regional and national allergology and clinical immunology societies. Since the first World Allergy Congress (WAC) held in Zurich, Switzerland in 1951, there have been 28 WACs as well as a number of WAO International Science Conferences (WISC), Webinars, and Symposia. Beyond sharing research findings, these meetings also allocate funds for postgraduate programs on allergy and clinical immunology.

Torsten Zuberbier is a German dermatologist and allergologist.

Laboratory animal allergy (LAA) is an occupational disease of laboratory animal technicians and scientists. It manifests as an allergic response to animal urine, specifically the major urinary proteins (Mups) of rodents, and can lead to the development of asthma. A study of 5641 workers in Japan who were exposed to laboratory animals found 23.1% had one or more allergic symptoms; globally the prevalence among at risk workers is estimated between 11 and 30% According to the National Institutes of Health, prevention of animal allergy depends on the control of allergens in the work environment. This involves a combination of measures to eliminate or control allergen exposure, including engineering controls, administrative controls, and personal protective equipment.

Igor Petrovych Kaidashev is a Ukrainian immunologist and allergist, MD, and Professor. Igor Kaidashev is President of the Ukrainian Society of Immunology, Allergy and Immunorehabilitation, Professor of the Department of Internal Medicine No. 3 with Phthisiology, and Vice-Rector for Research & Development at Poltava State Medical University (PSMU) since 2010.

<span class="mw-page-title-main">Alain de Weck</span> Swiss immunologist and allergist (1928–2013)

Alain L. de Weck,, was a Swiss immunologist and allergist. His main scientific contributions were in the area of characterization and prevention of drug allergy. He was the founding director of the Institute of Clinical Immunology at the University of Bern from 1971 to 1993 and authored or co-authored over 600 peer-reviewed publications. He is the recipient of a number of patents that led to commercial allergy products and services. He served as president of international scientific organizations such as the International Union of Immunological Societies (IUIS) and the International Association for Allergy and Clinical Immunology (IAACI) and was founder and later CEO of the Centre Médical des Grand-Places (CMG) company, acquired by Heska of Fort Collins in 1997. In later years he continued his research at the University of Navarra in Spain and wrote on a wide range of topics such as the distinction between science and pseudo-science, the emergence of genetically modified organisms (GMOs) and comparative health care policy.

Erika Jensen-Jarolim is an Austrian physician and medical researcher in immunology and allergies. She was formerly head of the Institute of Pathophysiology and Allergy Research at the Medical University of Vienna, and since 2011 has held the joint professorship in Comparative Medicine at the Medical University and the University of Veterinary Medicine Vienna, part of the inter-university Messerli Research Institute.

<span class="mw-page-title-main">Kari Nadeau</span> American Physician and scientist

Dr. Kari Nadeau is the Chair of the Department of Environmental Health at Harvard School of Public Health and John Rock Professor of Climate and Population Studies. She practices Allergy, Asthma, Immunology in children and adults. She has published over 400+ papers, many in the field of climate change and health. Dr. Nadeau, with a team of individuals and patients and families, has been able to help major progress and impact in the clinical fields of immunology, infection, asthma and allergy. Dr. Nadeau is a member of the National Academy of Medicine and the U.S. EPA Children’s Health Protection Committee.

Oral mite anaphylaxis (OMA), also known as pancake syndrome, is a disease in which a person gets symptoms after eating food contaminated with particular mites. The disease name comes from reports of people becoming ill after eating pancakes made from contaminated wheat or corn (maize) flour.

Gail Ina Greenberg Shapiro was an American pediatric allergist based in Seattle. She was a faculty member at the University of Washington School of Medicine. In 2001, she became the first democratically elected president of the American Academy of Allergy, Asthma, and Immunology (AAAAI).

Suranjith Seneviratne is a doctor from Sri Lanka who practices in allergology and immunology.

<span class="mw-page-title-main">Andrii Kurchenko</span>

Andrii Ihorovych Kurchenko is a Ukrainian dermatologist, immunologist and allergologist, Doctor of Sciences in Medicine, Professor, head of department of Clinical Immunology and Allergology at O.Bohomolets National Medical University. He is an Expert of the Scientific and Expert Council at the State Expert Center of the Ministry of Health of Ukraine, a Fellow of the European and American Academies of Allergology and Clinical Immunology and Vice-President of the Ukrainian Society of experts in Immunology, Allergology and Immune rehabilitation (UTIAI). He is Deputy-editor of the journal "Immunology and Allergology. Science and Practice", as well as a co-author of the national textbooks "Clinical and Laboratory Immunology" (2012) and "Immunology" (2013).

<span class="mw-page-title-main">Giorgio Walter Canonica</span> Italian allergist and pulmonologist

Giorgio Walter Canonica is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy since December 2016. He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT). He has served as Secretary General and President elect of World Allergy Organisation for six consecutive years and has served as president of the same organization during 2007–09. He is also the vice-president of INTERASMA.

Mimi Tang is an Australian immunologist allergist specialized in food oral immunotherapy, such as pairing exposure to peanut proteins with probiotics.

References

  1. "List of Previous Pravasi Bhartiya Samman". Archived from the original on 28 December 2014. Retrieved 28 December 2014.
  2. "World Allergy Organization".
  3. "Home".
  4. Hassan Mahboub, B. H.; Santhakumar, S; Soriano, J. B.; Pawankar, R (2010). "Asthma insights and reality in the United Arab Emirates". Annals of Thoracic Medicine. 5 (4): 217–221. doi:10.4103/1817-1737.69109. PMC   2954375 . PMID   20981181.